Drug Discovery World
MAY 13, 2024
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. A leading news story this week has been the announcement of positive Phase II results of a head and neck cancer trial, but there have been a number of other interesting clinical result announcements.
BioPharma Drive: Drug Pricing
MAY 13, 2024
Goldman Sachs and Eli Lilly are among those backing the startup, which claims its prospect could be more potent than the myelofibrosis therapies that have come to market in recent years.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
MAY 13, 2024
Reece Armstrong speaks to Melanie Adams-Cioaba , Senior Director and General Manager of pharma (cryo-EM), Thermo Fisher Scientific about advances in vaccine design. RA: How can rational design approaches help advance vaccine development? MA: Regarding vaccine development specifically, and the role my team plays in the development of cryogenic electron microscopy (cryo-EM) technology, we see the study and dissemination of virus structures, and the proteins that comprise them, as vital to vacc
Science Daily: Pharmacology News
MAY 13, 2024
Today's rate of atmospheric carbon dioxide increase is 10 times faster than at any other point in the past 50,000 years, researchers have found through a detailed chemical analysis of ancient Antarctic ice.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Drug Discovery World
MAY 13, 2024
The University of Texas MD Anderson Cancer Center has been awarded $20 million to strengthen neurodegeneration research. The donation was awarded to the Belfer Neurodegeneration Consortium (BNDC), which aims to develop five new medicines for Alzheimer’s disease and related disorders over the next 10 years, with the goal for two treatments to demonstrate clinical efficacy.
Science Daily: Pharmacology News
MAY 13, 2024
An experimental treatment made from a plant virus is effective at protecting against a broad range of metastatic cancers in mice, shows a new study. The treatment, composed of nanoparticles fashioned from the cowpea mosaic virus -- a virus that infects black-eyed pea plants -- showed remarkable success in improving survival rates and suppressing the growth of metastatic tumors across various cancer models, including colon, ovarian, melanoma and breast cancer.
Drug Discovery Digest brings together the best content for drug research and development professionals from the widest variety of industry thought leaders.
Science Daily: Pharmacology News
MAY 13, 2024
The human brain filters through a flood of experiences to create specific memories. Why do some of the experiences in this deluge of sensory information become 'memorable,' while most are discarded by the brain? A computational model and behavioral study developed by Yale scientists suggests a new clue to this age-old question, they report in the journal Nature Human Behavior.
Drugs.com
MAY 13, 2024
MONDAY, May 13, 2024 -- Women who get abortion pills through the mail receive care that's as good as those who are required to get them in person from a clinic or doctor’s office, a new study says. Using a mail-order pharmacy to deliver the.
Science Daily: Pharmacology News
MAY 13, 2024
in March a farm worker who reported no contact with sick or dead birds, but who was in contact with dairy cattle, began showing symptoms in the eye and samples were collected by the regional health department to test for potential influenza A. Experts have now confirmed the first case of highly pathogenic avian influenza transmission from a mammal (dairy cow) to a human.
FDA Law Blog: Biosimilars
MAY 13, 2024
By Jeffrey N. Gibbs & Ana Loloei & Véronique Li, Senior Medical Device Regulation Expert — FDA has long touted the use of real-world evidence ( RWE ). Extolling RWE, FDA has said “RWE can be leveraged to bring new products to market, evaluate the safety and effectiveness of existing products for new uses, and assess the continued performance and safety of products once on the market.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Drugs.com
MAY 13, 2024
MONDAY, May 13, 2024 -- People with heart failure are often prescribed what are known as loop diuretic medications to help reduce the fluid buildup that's a hallmark of the disease.Now, research suggests that taking the blockbuster weight loss drug.
Science Daily: Pharmacology News
MAY 13, 2024
Molecular biologists provide exciting insights into the bristles of the marine annelid worm Platynereis dumerilii. Specialized cells, so-called chaetoblasts, control the formation of the bristles. Their mode of operation is astonishingly similar to that of a technical 3D printer.
Drugs.com
MAY 13, 2024
MONDAY, May 13, 2024 (HealthDay news) -- Could being a lesbian or bisexual shorten your life? New research that analyzed decades of data on women suggests it might. What's driving the trend? Researchers point to discrimination as the primary.
BioPharma Drive: Drug Pricing
MAY 13, 2024
The deal — worth $100 million up front and potentially billions more later on — gives Takeda an exclusive option to license an Alzheimer’s vaccine and other “active immunotherapies.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Drugs.com
MAY 13, 2024
MONDAY, May 13, 2024 -- Rick Slayman, the first person to receive a kidney transplant from a genetically modified pig, has died nearly two months after having the historic surgery.In a statement released Saturday, Slayman's family said they were.
BioPharma Drive: Drug Pricing
MAY 13, 2024
The deal gives the pharma partial rights to a medicine GSK once developed for heart disease but could soon become the first therapy for facioscapulohumeral muscular dystrophy.
Drugs.com
MAY 13, 2024
MONDAY, May 13, 2024 -- Police seizures of illicit fentanyl pills have soared in recent years, a new study has found.The number of pills containing fentanyl seized by law enforcement was 2,300 times greater in 2023 than in 2017 – more than 115.
BioPharma Drive: Drug Pricing
MAY 13, 2024
The firm, which closed a $167 million fund, aims to fill a “crucial gap” by helping to grow the companies startups turn to for outsourced services, founder Todd Holmes told BioPharma Dive.
Drug Patent Watch
MAY 13, 2024
Annual Drug Patent Expirations for BALVERSA Balversa is a drug marketed by Janssen Biotech and is included in one NDA. It is available from one supplier.
Fierce BioTech
MAY 13, 2024
Bridging the Genetic Diagnosis Gap: Strategies for Expanding Access to Rare Disease Therapies pesurya Mon, 05/13/2024 - 13:44 Tue, 06/18/2024 - 13:00 Resource Type Webinar Heather McLaughlin, PhD, FACMG, NYCoQ, CGMB Michelle Hearn, CGC Colleen Caleshu, CGC Jeff Haroldson, PharmD Duration 60 Minutes As targeted treatments for rare diseases rapidly emerge, genetic diagnosis plays a crucial role in enabling access to clinical trials and precision therapies with the ultimate benefit of enhancing pat
Drug Patent Watch
MAY 13, 2024
Annual Drug Patent Expirations for PARSABIV Parsabiv is a drug marketed by Kai Pharms Inc and is included in one NDA. It is available from one supplier.
Perficient: Drug Development
MAY 13, 2024
Introduction to Selenium Web application testing is the primary use of Selenium, an open-source program that may be used for various tasks, such as web scraping and automating tedious tasks. Apart from supporting multiple programming languages, including Python, Java, C#, and others, it provides a suite of tools for automating web browsers across various platforms.
Drug Patent Watch
MAY 13, 2024
Annual Drug Patent Expirations for ERLEADA Erleada is a drug marketed by Janssen Biotech and is included in one NDA. It is available from one supplier.
Vial
MAY 13, 2024
Introduction The biopharma industry is poised to make revolutionary advances in and redefine drug development, and the current climate for innovation appears ideal. However, progress from molecule to approved drug is hampered by extremely high costs and lengthy clinical trials , and approximately 90% of drugs that reach clinical trials fail. We explore the causes underlying the high costs associated with drug development and what value contract research organizations (CROs) bring to sponsors in
Drug Patent Watch
MAY 13, 2024
Annual Drug Patent Expirations for VASCEPA Vascepa is a drug marketed by Amarin Pharms and is included in one NDA. It is available from two suppliers.
Perficient: Drug Development
MAY 13, 2024
Last week, I had the privilege of attending our Accelerate Conference in St. Louis where I learned that Perficient’s secret sauce is really our people. We are a global digital consulting firm competing against the largest consulting firms in the world – and yet, we stand out. We heard from a couple of our largest clients who spoke about the groundbreaking work we are doing together.
Drug Patent Watch
MAY 13, 2024
Annual Drug Patent Expirations for SCEMBLIX Scemblix is a drug marketed by Novartis and is included in one NDA. It is available from one supplier.
Drugs.com
MAY 13, 2024
MONDAY, May 13, 2024 -- Actress and "X-men" star Olivia Munn has revealed that she underwent egg retrieval and then a hysterectomy after being diagnosed with breast cancer. In an article published on Mother's Day, Munn told Vogue she opted for.
thought leadership
MAY 13, 2024
In today's dynamic business landscape, organizations in the drug, biologics, and medical device industries face the dual challenge of delivering quality products while managing tighter budgets and ensuring compliance with evolving regulatory standards. As companies strive to enhance product quality and meet stringent regulatory requirements to ensure the safety and efficacy of their products, vendor audits play a pivotal role.
Drugs.com
MAY 13, 2024
MONDAY, May 13, 2024 -- Yoga can help improve the long-term health of people with heart failure, a new study has found.“Patients who practiced yoga on top of taking their medications felt better, were able to do more, and had stronger hearts than.
Drug Patent Watch
MAY 13, 2024
Annual Drug Patent Expirations for NYMALIZE Nymalize is a drug marketed by Azurity and is included in one NDA. It is available from one supplier.
Drugs.com
MAY 13, 2024
MONDAY, May 13, 2024 -- About a third of young children who are allergic to peanuts will outgrow the allergy by the age of 10, and an antibody test might predict who those kids might be.
Drug Patent Watch
MAY 13, 2024
Annual Drug Patent Expirations for BRUKINSA Brukinsa is a drug marketed by Beigene and is included in one NDA. It is available from one supplier.
Drugs.com
MAY 13, 2024
MONDAY, May 13, 2024 -- “Skinny” fat cells might actually make it harder to lose weight and easier to pack on extra pounds, a new study says.Researchers say it’s possible to predict if someone’s going to gain weight based solely on the size.
Expert insights. Personalized for you.
147 
Let's personalize your content